Event Type
Disclosure
Mandatory
Variant
8-K
, including the attached Exhibit 99.1, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934,
Other Events. On March 3, 2026, the Company entered into an amended and restated sales agreement (the “Sales Agreement”) with TD Securities (USA) LLC (“TD Cowen
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 1.1 Amended and Restated Sales Agreement by and between Sana Biotechnology, Inc. and TD